BAKER BROS ADVISORS LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in XOMA Corp ($XOMA) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and a 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in Zymeworks Inc. ($ZYME) and a Director in Kodiak Sciences Inc. ($KOD) and a 10% Owner in Invitae Corp ($NVTA) and a Director in IGM Biosciences, Inc. ($IGMS) and a 10% Owner in Atreca, Inc. ($BCEL) and a in Mirati Therapeutics, Inc. ($MYG) and a 10% Owner in Mirati Therapeutics, Inc. ($MYG) and a Director in Talis Biomedical Corp ($TLIS) and a Director in Aeglea BioTherapeutics, Inc. ($AGLE) and a in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a in Intellia Therapeutics, Inc. ($NTLA) and a Director in BeiGene, Ltd. ($BGNE) and a Director in Prelude Therapeutics Inc ($PRLD) and a Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a in HOOKIPA Pharma Inc. ($HOOK).

Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY

Companies in which BAKER BROS ADVISORS LLC is an Insider

ACADIA PHARMACEUTICALS INC

Trading Symbol: ACAD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 3,476,727 shares
Current Value: $132,776,204
Latest Transaction: Jun 25 2020
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aeglea BioTherapeutics, Inc.

Trading Symbol: AGLE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 25 2021
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 997,764 shares
Current Value: $127,434,418
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Atreca, Inc.

Trading Symbol: BCEL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 309,730 shares
Latest Transaction: Jul 20 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BeiGene, Ltd.

Trading Symbol: BGNE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 10,418 shares
Current Value: $374,215
Latest Transaction: Dec 04 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BELLICUM PHARMACEUTICALS, INC

Trading Symbol: BLCM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 1,656,688 shares
Current Value: $9,393,421
Latest Transaction: Aug 16 2016
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 165,980 shares
Current Value: $4,562,790
Latest Transaction: Oct 03 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HOOKIPA Pharma Inc.

Trading Symbol: HOOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 72,128 shares
Latest Transaction: Apr 23 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IDERA PHARMACEUTICALS, INC.

Trading Symbol: IDRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner, Director
Holdings: 350,721 shares
Current Value: $547,125
Latest Transaction: Jul 03 2019
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IGM Biosciences, Inc.

Trading Symbol: IGMS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 267,065 shares
Latest Transaction: Feb 23 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 2,850,042 shares
Current Value: $336,817,964
Latest Transaction: Oct 02 2020
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Intellia Therapeutics, Inc.

Trading Symbol: NTLA
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAKER BROS ADVISORS LLC:
Holdings: 976,214 shares
Current Value: $12,983,646
Latest Transaction: May 11 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Invitae Corp

Trading Symbol: NVTA
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 845,858 shares
Current Value: $7,443,550
Latest Transaction: Mar 29 2018
$NVTA Market Capitalization: $281.95M
$NVTA Previous Close: $8.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kiniksa Pharmaceuticals, Ltd.

Trading Symbol: KNSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 98,980 shares
Latest Transaction: Jul 28 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kodiak Sciences Inc.

Trading Symbol: KOD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 1,024,982 shares
Latest Transaction: Sep 25 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Mirati Therapeutics, Inc.

Trading Symbol: MYG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 141,244 shares
Latest Transaction: Nov 20 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Neoleukin Therapeutics, Inc.

Trading Symbol: NLTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director, 10% Owner
Holdings: 320,049 shares
Current Value: $6,020,122
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Prelude Therapeutics Inc

Trading Symbol: PRLD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 876,061 shares
Latest Transaction: Jan 29 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 82,969 shares
Latest Transaction: Oct 06 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 4,082,851 shares
Current Value: $248,196,512
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Talis Biomedical Corp

Trading Symbol: TLIS
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 571,659 shares
Latest Transaction: Feb 19 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

XOMA Corp

Trading Symbol: XOMA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 90,538 shares
Current Value: $381,165
Latest Transaction: Jul 23 2015
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Zymeworks Inc.

Trading Symbol: ZYME
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: May 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC

Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021NLTXNeoleukin Therapeu ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA11.4025,000285,00025,000
Feb 25 2021AGLEAeglea BioTherapeu ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA7.1147,200335,59247,200
Feb 23 2021IGMSIGM Biosciences, I ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA91.506,423587,7056,423
Feb 19 2021TLISTalis Biomedical C ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM0.006,427,576027,511,741
Feb 19 2021TLISTalis Biomedical C ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM0.00536,43802,345,481
Feb 19 2021TLISTalis Biomedical C ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM0.007,286,794021,084,165
Feb 19 2021TLISTalis Biomedical C ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM0.00536,41401,809,043

View all BAKER BROS ADVISORS LLC insider transactions.